Alvaro R. Hernandez

Alvaro R. Hernandez

Auto-generated profile, based on publicly available information

Alvaro R. Hernandez

Department of Pathology, University of Cambridge, Cambridge, UK

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2026 in Science Immunology
Verified
Journal Article
Closed access
NMNtombizodwa Makuyana
Ntombizodwa Makuyana
LSLaura Seldeslachts
Laura Seldeslachts
LMLauren Michiels
Lauren Michiels
OBOliver T. Burton
Oliver T. Burton
AHAlvaro R. Hernandez
Alvaro R. Hernandez
ALAdrian Liston
Adrian Liston
Respiratory infections that result in severe and life-threatening immune-mediated respiratory decline are a major public health issue. Controlling local respiratory immune reactions without the use of systemic immunosuppressants remains an unmet clinical challenge. We developed a gene delivery system to express anti-inflammatory cytokines in the lung, which reestablishes local immune homeostasis without triggering systemic effects. Using an adeno-associated vector cargo system (AAV6.2- CC10 ), we induced production of interleukin-2 (IL-2), IL-1 receptor antagonist (IL-1RA), and IL-10 in situ in the lung microenvironment, with no detectable expression or immunological deviation in the peripheral immune system. We demonstrate the effective potential of IL-2, IL-1RA, and IL-10 as immunomodulatory cargos in severe infectious challenge, which reduced respiratory pathology after influenza-associated pulmonary aspergillosis. Thus, the AAV6.2- CC10 platform enables targeted delivery of biologics to the lung, modulates the lung environment, and improves pathology without inducing systemic immune reactions.